Cargando…
The Role of Dopamine D3 Receptors, Dysbindin, and Their Functional Interaction in the Expression of Key Genes for Neuroplasticity and Neuroinflammation in the Mouse Brain
Cognitive impairment in schizophrenia remains a clinically and pharmacologically unsolved challenge. Clinical and preclinical studies have revealed that the concomitant reduction in dysbindin (DYS) and dopamine receptor D3 functionality improves cognitive functions. However, the molecular machinery...
Autores principales: | Rivi, Veronica, Benatti, Cristina, Blom, Joan M. C., Pani, Luca, Brunello, Nicoletta, Drago, Filippo, Papaleo, Francesco, Caraci, Filippo, Geraci, Federica, Torrisi, Sebastiano Alfio, Leggio, Gian Marco, Tascedda, Fabio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10218262/ https://www.ncbi.nlm.nih.gov/pubmed/37240042 http://dx.doi.org/10.3390/ijms24108699 |
Ejemplares similares
-
Buspirone Counteracts MK-801-Induced Schizophrenia-Like Phenotypes through Dopamine D(3) Receptor Blockade
por: Torrisi, Sebastiano Alfio, et al.
Publicado: (2017) -
Dopamine, Cognitive Impairments and Second-Generation Antipsychotics: From Mechanistic Advances to More Personalized Treatments
por: Torrisi, Sebastiano Alfio, et al.
Publicado: (2020) -
Pharmacological and Genetic Evidence of Dopamine Receptor 3-Mediated Vasoconstriction in Isolated Mouse Aorta
por: Zingales, Veronica, et al.
Publicado: (2021) -
Antioxidant Activity of Fluoxetine and Vortioxetine in a Non-Transgenic Animal Model of Alzheimer’s Disease
por: Caruso, Giuseppe, et al.
Publicado: (2021) -
Fluoxetine Prevents Aβ(1-42)-Induced Toxicity via a Paracrine Signaling Mediated by Transforming-Growth-Factor-β1
por: Caraci, Filippo, et al.
Publicado: (2016)